MIRA
INFORM REPORT
|
Report Date : |
08.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
ARIES PHARMACEUTICAL (PVT) LIMITED |
|
|
|
|
Registered Office : |
47-Amin Mansion, G.T. Road, Peshawar |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1997 |
|
|
|
|
Com. Reg. No.: |
0038404 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Business Name
ARIES PHARMACEUTICAL (PVT) LIMITED
Full Address
Registered Address
47-Amin Mansion, G.T. Road, Peshawar, Pakistan
Tel 92 (91) 2217542, 2218476
Fax 92 (91) 2212239
Email ariespharma@hotmail.com
Short Description Of Business
|
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
Year Established |
1997 |
|
Registration # |
0038404 |
Factory Address
|
Address |
1-W, Industrial Estate, Hayatabad, Peshawar, Pakistan |
|
Tel # |
92 (91) 5829747, 5829748 |
|
Fax # |
92 (91) 5830163 |
Auditors
M/s Dilroze Khan & Co.
(Chartered
Accountants)
2nd Floor, F.C. Trust Building, Sunehri Masjid Road, Peshawar Cantt, Pakistan
Legal Status
Subject Company was established as a Private Limited Company in 1997
|
Authorized Capital |
Rs. 10,000,000/- divided into 100,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs 6,050,000/- divided into 60,500 shares of Rs. 100/- each |
Details of Directors
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Ghulam Sarwar Khan Mr. S.S. Bukhari Mr. M. Yousaf Sarwar Khan |
Pakistani Pakistani Pakistani |
47-Amin Mansion, G.T. Road, Peshawar 47-Amin Mansion, G.T. Road, Peshawar 47-Amin Mansion, G.T. Road, Peshawar |
Business Business Business |
Chief Executive Director Director |
Shareholders
|
Names |
|
Mr. Ghulam Sarwar Khan Mr. S.S. Bukhari Mr. M. Yousaf Sarwar Khan |
Associates
A. Subsidiary
None
B. Associated Companies
(1) Sunny Marketing Services, Pakistan
Products
Manufacture & Marketing of Pharmaceutical Products by its brand name including ADVIL, ALEVE, ALORAN, APTON, ARIFLOX, BACIDAL, CEFRADIN, EXCEDRIN EXTRA, FLAGYNASE, GLACTIL, HAEMATIC-F, KEFOLOR, PAXIL, PENETREX, PEPTIMA-V, PRILOSEC, QUIXIN, RELIZIN, ROCICIAN, SERAX, SPECTRACEF
Number of Employees
75
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2006 |
40,000,000/- (Estimated) |
Trade Suppliers (Foreign)
Subject represent some companies regarding pharmaceutical raw material belongs to India, China & Europe
Customers
Mainly Individuals, Retailers, Pharmacies, Hospitals located in Peshawar & Quetta.
Bankers
MCB Bank Limited, Pakistan.
Habib Bank Limited, Pakistan.(Mortgage obtained PKR 22,127,000/-)
Faysal Bank Limited, Pakistan.
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 61.65 |
|
UK Pound |
1 |
Rs. 122.10 |
|
Euro |
1 |
Rs. 91.20 |
Comments
Subject Company was established in 1997 and is engaged in manufacture & marketing of Pharmaceutical Products. Trade relations are reported as fair. Subject Company can be considered for normal business dealings at usual trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)